May 8, 2009 (Chicago, Illinois) — Findings from a small preliminary study indicate that the number of trophoblast cells collected by Papanicolaou (Pap) test in the first trimester of pregnancy can ...

Sacituzumab govitecan (SG), a first-in-class anti–trophoblast cell surface antigen 2 (Trop-2) antibody-drug conjugate, demonstrated superior efficacy over single-agent chemotherapy (treatment of ...

Pluripotent stem cells — which have the ability to differentiate into any cell type in the body — have enormous potential for regenerative medicine and for uncovering the developmental biology ...

Watch and Wait for Rectal Cancer: A Risky Gamble or a Safe Strategy for Patients With a Near-Complete Response? The article by Shimizu et al entitled “First-in-Human, Phase I Dose-Escalation and ...

In a milestone achievement for better understanding the development and function of the human placenta, scientists have derived and grown trophoblast stem cells for the first time. Led by Takahiro ...

Conventional human pluripotent stem cells at the primed pluripotent state are capable of generating all the embryonic lineages. However, their extraembryonic trophectoderm potentials is limited. It ...